Security key
03168L105
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)
CUSIP: 03168L105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Class A Common Stock, par value $0.01
- Total 13F shares
- 142,604,811
- Total 13F value
- $1,186,537,394
- Share change
- +3,241,628
- Put/Call ratio
- 86%
- SEC-reported price per share
- $8.32
- Number of holders
- 180
- Value change
- +$32,304,784
- Number of buys
- 88
- Number of sells
- 81
- Shares outstanding
- 348,532,261
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
180
Top holders
10
AMRX full security history
Ownership snapshot
Full 13F holder table
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 6.3%
Showing 1-6 of 15 holder rows.
Quick read
UBS Group AG leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Comparable ownership
Top 5
UBS Group AG
6.3%
VANGUARD GROUP INC
4%
TPG GP A, LLC
3.5%
BlackRock Finance, Inc.
3.2%
Rubric Capital Management LP
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
6.3%
|
$138,744,471
21,849,523 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4%
|
$88,863,030
13,994,178 shares
|
— | 30 Jun 2024 |
| TPG GP A, LLC |
13F
3/4/5
Company · Former 10% Owner
|
3.5%
|
$78,287,670
12,328,767 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
3.2%
|
$71,643,429
11,282,430 shares
|
— | 30 Jun 2024 |
| Rubric Capital Management LP |
13F
Company
|
3.1%
|
$68,083,290
10,721,778 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.9%
|
$63,428,404
9,988,725 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
180
Shares
142,604,811
Rows available
180
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
179
Q3 2024 holders
180
Holder diff
1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|